Conmed CNMD reported its Q3 earnings results on Wednesday, October 26, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Conmed beat estimated earnings by 2.67%, reporting an EPS of $0.77 versus an estimate of $0.75.
Revenue was up $26.26 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.01 which was followed by a 4.14% drop in the share price the next day.
Here's a look at Conmed's past performance:
Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
---|---|---|---|---|
EPS Estimate | 0.75 | 0.62 | 1.06 | 0.76 |
EPS Actual | 0.76 | 0.70 | 1.07 | 0.80 |
Revenue Estimate | 274.20M | 235.77M | 278.76M | 255.53M |
Revenue Actual | 277.19M | 242.33M | 273.97M | 248.83M |
To track all earnings releases for Conmed visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.